TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes
Public ClinicalTrials.gov record NCT01829464. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral Fasiglifam 25 mg and 50 mg Compared to Placebo When Used in Combination With Sitagliptin in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effect of TAK-875 (fasiglifam) in combination with sitagliptin on glycemic control in adults with type 2 diabetes.
Study identification
- NCT ID
- NCT01829464
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 90 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2013 (Type not available)
- Primary completion
- Feb 2014 (Actual)
- Completion
- Mar 2014 (Actual)
- Last update posted
- Jun 1, 2016
2013 – 2014
United States locations
- U.S. sites
- 82
- U.S. states
- 27
- U.S. cities
- 81
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Dothan | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Anaheim | California | — | — |
| Not listed | El Cajon | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Modesto | California | — | — |
| Not listed | North Hollywood | California | — | — |
| Not listed | Norwalk | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Vista | California | — | — |
| Not listed | West Hills | California | — | — |
| Not listed | Boca Raton | Florida | — | — |
| Not listed | Boynton Beach | Florida | — | — |
| Not listed | Bradenton | Florida | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | Cocoa | Florida | — | — |
| Not listed | Doral | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | North Miami | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Port Orange | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Savannah | Georgia | — | — |
| Not listed | Woodstock | Georgia | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Meridian | Idaho | — | — |
| Apex Medical Research, MI, Inc | Chicago | Illinois | 60616 | — |
| Not listed | Chicago | Illinois | — | — |
| Not listed | Avon | Indiana | — | — |
| Not listed | Greenfield | Indiana | — | — |
| Not listed | Muncie | Indiana | — | — |
| Not listed | Council Bluffs | Iowa | — | — |
| Not listed | Topeka | Kansas | — | — |
| Not listed | Owensboro | Kentucky | — | — |
| Not listed | Oxon Hill | Maryland | — | — |
| Not listed | Fall River | Massachusetts | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Washington | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Nashua | New Hampshire | — | — |
| Not listed | Elizabeth | New Jersey | — | — |
| Not listed | Haddon Heights | New Jersey | — | — |
| Not listed | Albany | New York | — | — |
| Not listed | Rosedale | New York | — | — |
| Not listed | Calabash | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Greensboro | North Carolina | — | — |
| Not listed | Morganton | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Maumee | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Feasterville | Pennsylvania | — | — |
| Not listed | Harleysville | Pennsylvania | — | — |
| Not listed | Levittown | Pennsylvania | — | — |
| Not listed | Uniontown | Pennsylvania | — | — |
| Not listed | Fort Mill | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Spartanburg | South Carolina | — | — |
| Not listed | Crossville | Tennessee | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Carrollton | Texas | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Irving | Texas | — | — |
| Not listed | Katy | Texas | — | — |
| Not listed | Lewisville | Texas | — | — |
| Not listed | McKinney | Texas | — | — |
| Not listed | New Braunfels | Texas | — | — |
| Not listed | Plano | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Tomball | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Manassas | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01829464, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 1, 2016 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01829464 live on ClinicalTrials.gov.